Updated:
Long's Drugs Incorporated
Long's Drugs Incorporated family office manages wealth from the 2008 sale to CVS. Founded 1938 by Joseph Long. Columbia, MO.
Long's Drugs Incorporated
Founded by Joseph S. Long in 1938, Long's Drugs Incorporated began as a single pharmacy in Oakland, California, and expanded to become the largest independent drugstore chain in the western United States. By 2008, the company operated 213 stores across California, Hawaii, Nevada, and Oregon, employing over 13,000 people. The Long family maintained control for nearly 70 years before selling the chain to CVS Caremark in October 2008 for approximately $2.7 billion. The family office that emerged from the sale likely deploys the residual capital across a conservative mix of public equities, fixed income, and real estate, consistent with wealth preservation mandates common among single-family offices. Specific asset-allocation figures and direct portfolio holdings remain undisclosed per public filings. The primary office is located in Columbia, Missouri, where some family members have ties. No additional offices, professional headcount, or philanthropic vehicles have been publicly disclosed. The firm's current investment activity is not observable in public records. As a single-family office handling the proceeds of a single-chain disposition, the firm's structural differentiator is its finite, non-replenishing capital base. Unlike operating-company-controlled family offices, Long's Drugs must preserve capital without ongoing cash flow from an active business, which likely drives a more conservative, income-oriented allocation strategy.
General information
Firm type
other
Year founded
1938
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Columbia
Corporate office
Columbia, MO, United States
Sector focus
Frequently asked questions
Who controls Long's Drugs Incorporated today?
Control rests with the Long family, though no specific principal or title has been publicly disclosed. The firm is registered in Missouri with an address in Columbia.
What is the investment mandate of the Long's Drugs family office?
The mandate is not publicly stated, but based on typical post-disposition family offices, the focus is likely wealth preservation through a diversified portfolio of public equities, bonds, and real estate. No alternative-investment activity has been observed.
Does Long's Drugs family office make direct investments in private companies?
No public records indicate direct private investment activity. The office appears to operate as a passive wealth management vehicle rather than an active strategic investor.
How large is the current pool of capital managed by Long's Drugs family office?
The exact figure is undisclosed. The office represents the residual from the $2.7 billion CVS acquisition in 2008, adjusted for taxes, distributions to family members, and investment returns over 18 years.
Is Long's Drugs family office active in philanthropy?
No separate philanthropic foundation or trust is publicly associated with the Long family or the office. Any charitable activity is likely informal or through personal donor-advised funds.
Does the Long's Drugs family office allocate to external managers?
This information is not public. The office may use external asset managers, but no filings or press coverage confirm specific relationships.
What is the relationship between Long's Drugs family office and CVS today?
After the 2008 acquisition, the Long family exited operational control. There is no public evidence of remaining business ties or ongoing financial interests beyond any retained shares in the combined entity.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: